NATICK, Mass., July 1, 2026 (SEND2PRESS NEWSWIRE) -- NeuroDex, a precision diagnostics company specializing in the isolation and analysis of neuron-derived extracellular vesicles (NDEs) from blood, today announced new findings supporting NDE-associated TDP-43 as a treatment-responsive biomarker in amyotrophic lateral sclerosis (ALS).

https://www.send2press.com/wire/neurodex-exosort-platform-demonstrates-treatment-responsive-blood-based-measurement-of-neuronal-tdp-43-in-people-living-with-als/

#send2press